Paramyxoviridae Infections - 25 Studies Found Status Study Completed Study Name: Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and Children Condition: Paramyxoviridae Infections Virus Diseases Date: 2009-11-25 Interventions: Drug: rHPIV3cp45 10^5 TCID50 n Completed Study Name: Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults Condition: Paramyxoviridae Infections Virus Diseases Date: 2006-08-17 Interventions: Biological: rB/HPIV3 Live atte Completed Study Name: Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants Condition: Paramyxoviridae Infections Virus Diseases Date: 2006-03-28 Interventions: Biological: rHPIV3cp45 Placebo Active, not recruiting Study Name: The Respiratory Protection Effectiveness Clinical Trial Condition: Influenza Respiratory Syncytial Viruses Device: N95 Respirator Partici Completed Study Name: Surveillance Study of Viral Infections Following Lung Transplantation Condition: Lung Transplantation Bronchiolitis Obliterans Epstein-Barr Date: 2008-06-17 Completed Study Name: An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection Condition: Parainfluenza Date: 2013-07-11 Interventions: Drug: DAS181-F02 Dry Powder in Bulk Active, not recruiting Study Name: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen Condition: Parainfluenza Date: 2012-07-17 Interventions: Drug: DAS181 dry powder, formulation F02 D Completed Study Name: Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and Children Condition: Parainfluenza Virus 3, Human Date: 2010-12-02 Interventions: Biological: rHPIV3cp45 Vaccine Completed Study Name: Safety of a Live Attenuated Human Parainfluenza Virus Type 2 (HPIV2) Vaccine for Adults, Children, and Infants Condition: Human Parainfluenza Virus 2 Date: 2010-06-07 Interventions: Biological: Standard Dose HPIV2 Vaccine Completed Study Name: A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to <24 Month-old Children and in 2 Month-old Infants Condition: Healthy Date: 2008-05-23 Interventions: Biological: MEDI-534, Cohort 1 Next >>>